MINAPHARM Pharmaceuticals (CASE: MIPH)
Health Care · Pharmaceuticals · EG
EGP812.49
+0.32% today · +205.2% 1Y
MINAPHARM Pharmaceuticals (CASE: MIPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $182.84M.
Over the last twelve months the share price has gained 205.2%, trading between 256.01 and 1.00K.
Tweenvest scores MINAPHARM Pharmaceuticals across four factors: quality 65/100, value 37/100, growth 53/100, dividend 22/100. Its strongest factor is quality.
MIPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $182.84M
- Revenue (TTM)
- $121.79M
- P/E
- 28.23
- EPS
- 28.78
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.33
- 52-week high
- EGP1,000.00
- 52-week low
- EGP256.01
- Avg volume (3M)
- —
- Shares outstanding
- 11.78M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Korea United Pharm Inc.KOSE: A033270 | $186.00M | ₩17,530.00 | -0.57% |
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $184.39M | NT$59.10 | -2.15% |
| Dawnrays Pharmaceutical (Holdings) LimitedSEHK: 2348 | $184.26M | HK$0.96 | -0.52% |
| AN2 Therapeutics, Inc.NasdaqGS: ANTX | $183.02M | $4.68 | -3.51% |
| Formosa Laboratories, Inc.TWSE: 4746 | $181.58M | NT$48.10 | +0.10% |
| Anlon Healthcare LimitedNSEI: AHCL | $181.40M | Rs32.86 | +4.28% |
| Fidson Healthcare PlcNGSE: FIDSON | $178.88M | ₦82.00 | -3.53% |
| Highnoon Laboratories LimitedKASE: HINOON | $177.29M | PKRs927.73 | +0.06% |
Figures last refreshed Oct 4, 2026.